Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any central precocious puberty in which the cause of the disease is a mutation in the KISS1R gene.
Features include sometimes findings: Hypothyroidism. 5 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 2 | Elevated circulating luteinizing hormone level, Elevated circulating follicle stimulating hormone level |
KISS1R encodes KISS1 receptor (398 aa). Receptor for kisspeptins (kisspeptin-10, kisspeptin-13, kisspeptin-14 and metastin/kisspeptin-54). Highest expression in Brain Hypothalamus (3.2 TPM) and Cells EBV-transformed lymphocytes (2.5 TPM).
Central precocious puberty 1 is associated with mutations in the KISS1R gene on chromosome 19.
KISS1R is classified as a druggable target (Cell Surface, Druggable Genome, G Protein Coupled Receptor, and Transporter categories) with score 6.5.
Genetic testing for KISS1R is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for central precocious puberty 1 has been reported in the published literature.
No clinical trials have been registered for central precocious puberty 1.
206 publications have been identified in PubMed for central precocious puberty 1. Kisho has analyzed 86 by research type. Research spans Review / Meta-Analysis (27%), Epidemiology / Natural History (27%), and Basic Science / Preclinical (15%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 23 | 27% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 7:48 AM UTC
Online Mendelian Inheritance in Man
2 |
Hypothyroidism, Isosexual precocious puberty |
Growth and development | 1 | Short stature |
Age of onset: adulthood.
Disease patterns and progression
23 |
27% |
Laboratory research | 13 | 15% |
Testing and diagnosis research | 8 | 9% |
Patient case studies | 8 | 9% |
Clinical study results | 7 | 8% |
Other research | 3 | 3% |
New treatment approaches | 1 | 1% |
Fan Y (2026). [PMID: 42235281](https://pubmed.ncbi.nlm.nih.gov/42235281/). *Ecotoxicol Environ Saf*. [Epidemiology / Natural History]
Canton APM (2026). [PMID: 41139199](https://pubmed.ncbi.nlm.nih.gov/41139199/). *J Clin Endocrinol Metab*. [Case Report / Case Series]
Li B (2026). [PMID: 42070902](https://pubmed.ncbi.nlm.nih.gov/42070902/). *Ann Pediatr Endocrinol Metab*. [Review / Meta-Analysis]
Hueg TK (2026). [PMID: 41091641](https://pubmed.ncbi.nlm.nih.gov/41091641/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Lages AS (2026). [PMID: 41912296](https://pubmed.ncbi.nlm.nih.gov/41912296/). *Vitam Horm*. [Review / Meta-Analysis]
Jiang M (2026). [PMID: 40355541](https://pubmed.ncbi.nlm.nih.gov/40355541/). *Pediatr Res*. [Review / Meta-Analysis]
Özer E (2026). [PMID: 41884206](https://pubmed.ncbi.nlm.nih.gov/41884206/). *Front Endocrinol (Lausanne)*. [Epidemiology / Natural History]
Sharma L (2026). [PMID: 31335042](https://pubmed.ncbi.nlm.nih.gov/31335042/). *Unknown Journal*. [Epidemiology / Natural History]
Robilliard R (2026). [PMID: 41383814](https://pubmed.ncbi.nlm.nih.gov/41383814/). *JCEM Case Rep*. [Case Report / Case Series]
Faria AG (2025). [PMID: 40366083](https://pubmed.ncbi.nlm.nih.gov/40366083/). *Arch Endocrinol Metab*. [Case Report / Case Series]
AI-curated news mentioning central precocious puberty 1
Updated Jul 21, 2026
A rare case report details the occurrence of central precocious puberty in a child with Sjogren-Larsson syndrome. This study contributes to the understanding of the interplay between these two rare conditions.